Scarica l'app Stockscreener
6.37
2.30%
-0.15
Pre-mercato:
6.51
0.14
+2.20%
Precedente Chiudi:
$6.52
Aprire:
$6.59
Volume 24 ore:
702.25K
Relative Volume:
0.69
Capitalizzazione di mercato:
$508.37M
Reddito:
$116.30M
Utile/perdita netta:
$17.73M
Rapporto P/E:
30.33
EPS:
0.21
Flusso di cassa netto:
$20.88M
1 W Prestazione:
-1.85%
1M Prestazione:
-7.28%
6M Prestazione:
-53.26%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$6.35
$6.62
Intervallo di 1 settimana:
$6.35
$6.77
Portata 52W:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Nome
Niagen Bioscience Inc
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Confronta NAGE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
6.37 | 520.34M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2019-10-16 | Iniziato | Oppenheimer | Outperform |
| 2019-02-14 | Iniziato | B. Riley FBR | Buy |
| 2017-11-27 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
Trade Recap: Is Niagen Bioscience Inc stock a smart buy before Fed meeting2025 Market Overview & Daily Market Momentum Tracking - moha.gov.vn
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
How Niagen Bioscience Inc. (OCD1) stock reacts to fiscal policiesMarket Performance Report & Precise Buy Zone Tips - Newser
How Niagen Bioscience Inc. (OCD1) stock behaves under inflation pressureGold Moves & Low Risk High Reward Trade Ideas - Newser
A History of Outperforming Analyst Forecasts and Beating the Odds: Niagen Bioscience Inc (NAGE) - setenews.com
Can Niagen Bioscience Inc. (OCD1) stock sustain breakout momentumWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Why Niagen Bioscience Inc. (OCD1) stock benefits from AI revolutionPortfolio Performance Report & Long-Term Growth Portfolio Plans - Newser
Is Niagen Bioscience Inc a good long term investmentTop Performing Stocks & Big Profit Small Budget - earlytimes.in
Taking the lead: Niagen Bioscience Inc (NAGE) - Setenews
A Look at Niagen Bioscience (NAGE) Valuation After New Skincare Launch and Long COVID Study Results - Sahm
How strong is Niagen Bioscience Inc. stock balance sheet2025 Market Trends & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
Niagen Bioscience (NAGE): Evaluating Valuation After Long COVID Study and Tru Niagen Beauty Launch - Yahoo Finance
Niagen Bioscience launches beauty supplement - Drug Store News
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates - MSN
Will Niagen Bioscience Inc. (OCD1) stock justify high valuationWatch List & Stepwise Trade Signal Guides - newser.com
Is Niagen Bioscience Inc. stock a bargain at current levelsEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Hope for Long-Covid Sufferers: Sponsored by Niagen Bioscience - KTLA
How Niagen Bioscience Inc. (OCD1) stock correlates with oil marketsPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Why Niagen Bioscience Inc. (OCD1) stock appears on watchlistsJuly 2025 Macro Moves & Real-Time Buy Zone Alerts - newser.com
Is Niagen Bioscience Inc. stock a buy on dipsQuarterly Growth Report & High Accuracy Investment Entry Signals - newser.com
Best data tools to analyze Niagen Bioscience Inc. stockJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
How high can Niagen Bioscience Inc. stock goJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
Is Niagen Bioscience Inc. stock undervalued vs historical averages - newser.com
Is Niagen Bioscience Inc. trending in predictive chart models2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Will Niagen Bioscience Inc. (OCD1) stock outperform value peersJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com
Niagen Bioscience (NASDAQ:NAGE) CFO Acquires 4,465 Shares - MarketBeat
Niagen Bioscience Inc Azioni (NAGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):